June 15, 2016
Janssen Biotech Inc. on Tuesday accused a General Electric unit in Utah federal court of infringing its patent for a cell culture media used to grow Inflectra, Celltrion Healthcare Co. and Hospira Inc.'s biosimilar of Janssen's blockbuster immunosuppressant Remicade.